Articles tagged as

Food and Drug Administration

  1. ETF Analysis: ALPS Medical Breakthroughs

  2. Celgene Vs. Gilead: Vetting for the Best Biopharma

  3. ETF Analysis: Market Vectors Pharmaceutical

  4. 10 Developments By Gilead Sciences That Could Boost Profits

  5. How to Profit from the Generic Drug Trend

  6. How Does Biogen Make its Money?

  7. How NDAs Work and Why They're Important

  8. Could Amgen's Next Drug Be Worth $100 Billion?

  9. 3 Things That Could Hold Intuitive Surgical Back

  10. Did Orexigen Make A Big Mistake?

  11. Are These Biogen Idec's Next Blockbusters?

  12. Why Does Wall Street Hate MannKind?

  13. What’s The Drug That Will Finally Fight Obesity?

  14. Is Ariad On Track To Lose More Shares?

  15. What Is Amgen’s New Target?

  16. Will MannKind Finally Reach A Solid Ground?

  17. What Are The Real Economic Costs Of Obesity?

  18. Gilead Sciences: The New Market-Share Leader

  19. A Checklist For Successful Medical Technology Investment

  20. Getting Started In Stocks

  21. Top 4 Most Scandalous Insider Trading Debacles

  22. 8 Stages Of New Drug Development

  23. Investing In Medical Equipment Companies

  24. Using DCF In Biotech Valuation

  25. Investing In The Biotech Sector

  26. 4 Reasons Why You Love To Hate Big Businesses

  27. Evaluating Pharmaceutical Companies

  28. A Primer On The Biotech Sector

  29. Government Regulations: Do They Help Businesses?

  30. 7 Popular Diet Plans And What They Cost

  31. Baby Boomers Beware: Financial Fraud That Targets Seniors

  32. Scandals That Bring The CEOs Out

  33. Infamous Female Financiers

  34. A Year In Product Recalls

  35. Pharma Patent Trolls: Cheap Drugs At A Steep Price

  36. Investing In The Healthcare Sector

  37. Chasing Down Biotech Zombie Stocks

  38. The Ups And Downs Of Biotechnology

Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!